Takeda Pharmaceutical Company Limited

TSE:4502 Stock Report

Market Cap: JP¥6.8t

Takeda Pharmaceutical Balance Sheet Health

Financial Health criteria checks 3/6

Takeda Pharmaceutical has a total shareholder equity of ¥7,799.2B and total debt of ¥5,481.0B, which brings its debt-to-equity ratio to 70.3%. Its total assets and total liabilities are ¥16,227.7B and ¥8,428.5B respectively. Takeda Pharmaceutical's EBIT is ¥509.2B making its interest coverage ratio 5.1. It has cash and short-term investments of ¥804.3B.

Key information

70.3%

Debt to equity ratio

JP¥5.48t

Debt

Interest coverage ratio5.1x
CashJP¥804.27b
EquityJP¥7.80t
Total liabilitiesJP¥8.43t
Total assetsJP¥16.23t

Recent financial health updates

Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt

Jun 11
Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt

Recent updates

Why Investors Shouldn't Be Surprised By Takeda Pharmaceutical Company Limited's (TSE:4502) P/E

Sep 20
Why Investors Shouldn't Be Surprised By Takeda Pharmaceutical Company Limited's (TSE:4502) P/E

Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Aug 08
Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Aug 02
Earnings Beat: Takeda Pharmaceutical Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Jul 25
Takeda Pharmaceutical (TSE:4502) Is Increasing Its Dividend To ¥98.00

Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Jul 11
Takeda Pharmaceutical's (TSE:4502) Upcoming Dividend Will Be Larger Than Last Year's

Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year

Jun 30
Takeda Pharmaceutical Company Limited (TSE:4502) Yearly Results: Here's What Analysts Are Forecasting For This Year

Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt

Jun 11
Takeda Pharmaceutical (TSE:4502) Takes On Some Risk With Its Use Of Debt

Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings

May 21
Some Investors May Be Willing To Look Past Takeda Pharmaceutical's (TSE:4502) Soft Earnings

Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next

May 12
Takeda Pharmaceutical Company Limited Just Recorded A 6.0% EPS Beat: Here's What Analysts Are Forecasting Next

Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00

Mar 28
Takeda Pharmaceutical (TSE:4502) Is Due To Pay A Dividend Of ¥94.00

Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00

Mar 13
Takeda Pharmaceutical (TSE:4502) Has Announced A Dividend Of ¥94.00

Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00

Feb 26
Takeda Pharmaceutical (TSE:4502) Will Pay A Dividend Of ¥94.00

Financial Position Analysis

Short Term Liabilities: 4502's short term assets (¥3,107.5B) exceed its short term liabilities (¥2,465.2B).

Long Term Liabilities: 4502's short term assets (¥3,107.5B) do not cover its long term liabilities (¥5,963.2B).

Debt to Equity History and Analysis

Debt Level: 4502's net debt to equity ratio (60%) is considered high.

Reducing Debt: 4502's debt to equity ratio has reduced from 116% to 70.3% over the past 5 years.

Debt Coverage: 4502's debt is not well covered by operating cash flow (14.5%).

Interest Coverage: 4502's interest payments on its debt are well covered by EBIT (5.1x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y